MYCOPLASMA-FERMENTANS (INCOGNITUS STRAIN) CELLS ARE ABLE TO FUSE WITH T-LYMPHOCYTES

被引:15
作者
DIMITROV, DS
FRANZOSO, G
SALMAN, M
BLUMENTHAL, R
TARSHIS, M
BARILE, MF
ROTTEM, S
机构
[1] HEBREW UNIV JERUSALEM,HADASSAH MED SCH,DEPT MEMBRANE & ULTRASTRUCT RES,POB 1172,IL-91010 JERUSALEM,ISRAEL
[2] NCI,MATH BIOL LAB,MEMBRANE STRUCT & FUNCT SECT,BETHESDA,MD 20892
[3] US FDA,CTR BIOL EVALUAT & RES,MYCOPLASMA LAB,BETHESDA,MD 20014
关键词
D O I
10.1093/clinids/17.Supplement_1.S305
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Characteristics of the fusion of Mycoplasma fermentans (incognitus strain) with cultured lymphocytes were investigated. The rate and extent of fusion were monitored continuously in an assay that measured lipid mixing on the basis of dequenching of a fluorescent probe, octadecylrhodamine (R18), incorporated into mycoplasmas. Fusion of M. fermentans was detected with CD4+ (Molt-3) cells, CD4- (12E1) cells, and primary peripheral-blood lymphocytes. The level of fusion was relatively low (8%-12%). Detection of a similarly low level of fusion by fluorescence microscopy suggested the involvement of a specific lymphocyte subpopulation. After a short lag period, fusion at 37-degrees-C proceeded exponentially for approximately 30 minutes and was virtually complete at 60 minutes. Throughout the process, lymphocytes remained intact. Fusion was stimulated by CaCl2 but not by MgCl2; its inhibition by antisera to M. fermentans and by pretreatment of M. fermentans with proteolytic enzymes implied that the mycoplasmas possessed a proteinase-sensitive receptor involved in fusion. Mycoplasmas were rendered nonfusogenic by treatment with the uncoupler CCCP (carbonyl cyanide m-chlorophenylhydrazone; 5 muM) but were unaffected by treatment with chlorpromazine (10 muM) or DCCD (dicyclohexylcarbodiimide; 50 muM); these findings suggested that a proton gradient across the cell membrane is required for fusion.
引用
收藏
页码:S305 / S308
页数:4
相关论文
共 19 条
[1]  
Barile MF, 1979, MYCOPLASMAS, V2, P425
[2]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[3]  
CITOVSKY V, 1988, J BIOL CHEM, V263, P461
[4]   NON-BILAYER LIPID STRUCTURES IN MODEL AND BIOLOGICAL-MEMBRANES [J].
DEKRUIJFF, B ;
CULLIS, PR ;
VERKLEIJ, AJ .
TRENDS IN BIOCHEMICAL SCIENCES, 1980, 5 (03) :79-81
[5]   INITIAL-STAGES OF HIV-1 ENVELOPE GLYCOPROTEIN-MEDIATED CELL-FUSION MONITORED BY A NEW ASSAY BASED ON REDISTRIBUTION OF FLUORESCENT DYES [J].
DIMITROV, DS ;
GOLDING, H ;
BLUMENTHAL, R .
AIDS RESEARCH AND HUMAN RETROVIRUSES, 1991, 7 (10) :799-805
[6]  
Duzgunes N, 1985, Subcell Biochem, V11, P195
[7]  
HAROLD FM, 1982, CURR TOP MEMBR TRANS, V16, P485
[8]   PROTECTIVE ACTIVITY OF TETRACYCLINE ANALOGS AGAINST THE CYTOPATHIC EFFECT OF THE HUMAN IMMUNODEFICIENCY VIRUSES IN CEM CELLS [J].
LEMAITRE, M ;
GUETARD, D ;
HENIN, Y ;
MONTAGNIER, L ;
ZERIAL, A .
RESEARCH IN VIROLOGY, 1990, 141 (01) :5-16
[9]   VIRUS-LIKE INFECTIOUS AGENT (VLIA) IS A NOVEL PATHOGENIC MYCOPLASMA - MYCOPLASMA-INCOGNITUS [J].
LO, SC ;
SHIH, JWK ;
NEWTON, PB ;
WONG, DM ;
HAYES, MM ;
BENISH, JR ;
WEAR, DJ ;
WANG, RYH .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1989, 41 (05) :586-600
[10]   ENHANCEMENT OF HIV-1 CYTOCIDAL EFFECTS IN CD4+ LYMPHOCYTES BY THE AIDS-ASSOCIATED MYCOPLASMA [J].
LO, SC ;
TSAI, S ;
BENISH, JR ;
SHIH, JWK ;
WEAR, DJ ;
WONG, DM .
SCIENCE, 1991, 251 (4997) :1074-1076